*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| C6212 - Malignant neoplasm of descended left testis - as a primary diagnosis code | C6212 - Malignant neoplasm of descended left testis - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 6.73 | |
| Readmission Rate (%) | 43.84 | |
| Unplanned Readmission Rate (%) | NA | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 711: TESTES PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|
| Total Hospitalizations at DRG | 1,428 |
| Total Hospitalizations with ICD C6212 - Malignant neoplasm of descended left testis | 17 |
| DRG Share of Total Hospitalizations | 0.0 |
| % of Total ICD C6212 - Malignant neoplasm of descended left testis in DRG | 56.67 |
| Avg LOS at DRG | 7.26 |
| Avg LOS with ICD C6212 - Malignant neoplasm of descended left testis | 9.35 |
| Readmission Rate at DRG | 20.22 |
| Readmission Rate with ICD C6212 - Malignant neoplasm of descended left testis | NA |
| Unplanned Readmission Rate at DRG | 12.19 |
| Unplanned Readmission Rate with ICD C6212 - Malignant neoplasm of descended left testis | NA |
| Total Medicare payments at DRG | $20,276,943 |
| Total Medicare payments with ICD C6212 - Malignant neoplasm of descended left testis | $257,927 |
| Total Medicare payment per Day at DRG | $1,957 |
| Total Medicare payment per Day with ICD C6212 - Malignant neoplasm of descended left testis | $1,622 |
| Total Medicare payment per Hospitalization at DRG | $14,200 |
| Total Medicare payment per Hospitalization with ICD C6212 - Malignant neoplasm of descended left testis | $15,172 |
| Total Medicare Charges at DRG | $101,741,263 |
| Total Medicare Charges with ICD C6212 - Malignant neoplasm of descended left testis | $1,627,563 |
| Avg Charges at DRG | $71,247 |
| Avg Charges with ICD C6212 - Malignant neoplasm of descended left testis | $95,739 |
| Mortality Rate at DRG | NA |
| Mortality Rate with ICD C6212 - Malignant neoplasm of descended left testis | NA |
| SNF Discharge Rate at DRG | 22.13 |
| SNF Discharge Rate with ICD C6212 - Malignant neoplasm of descended left testis | NA |
| Home Discharge Rate at DRG | 47.97 |
| Home Discharge Rate with ICD C6212 - Malignant neoplasm of descended left testis | NA |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 711: TESTES PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|
| Total Hospitalizations at DRG | 1,428 | |
| Total Hospitalizations with ICD C6212 - Malignant neoplasm of descended left testis | 18 | |
| DRG Share of Total Hospitalizations | 0.0 | |
| % of Total ICD C6212 - Malignant neoplasm of descended left testis in DRG | 22.78 | |
| Avg LOS at DRG | 7.26 | |
| Avg LOS with ICD C6212 - Malignant neoplasm of descended left testis | 8.89 | |
| Readmission Rate at DRG | 20.22 | |
| Readmission Rate with ICD C6212 - Malignant neoplasm of descended left testis | NA | |
| Unplanned Readmission Rate at DRG | 12.19 | |
| Unplanned Readmission Rate with ICD C6212 - Malignant neoplasm of descended left testis | NA | |
| Total Medicare payments at DRG | $20,276,943 | |
| Total Medicare payments with ICD C6212 - Malignant neoplasm of descended left testis | $270,693 | |
| Total Medicare payment per Day at DRG | $1,957 | |
| Total Medicare payment per Day with ICD C6212 - Malignant neoplasm of descended left testis | $1,692 | |
| Total Medicare payment per Hospitalization at DRG | $14,200 | |
| Total Medicare payment per Hospitalization with ICD C6212 - Malignant neoplasm of descended left testis | $15,039 | |
| Total Medicare Charges at DRG | $101,741,263 | |
| Total Medicare Charges with ICD C6212 - Malignant neoplasm of descended left testis | $1,642,038 | |
| Avg Charges at DRG | $71,247 | |
| Avg Charges with ICD C6212 - Malignant neoplasm of descended left testis | $91,224 | |
| Mortality Rate at DRG | NA | |
| Mortality Rate with ICD C6212 - Malignant neoplasm of descended left testis | NA | |
| SNF Discharge Rate at DRG | 22.13 | |
| SNF Discharge Rate with ICD C6212 - Malignant neoplasm of descended left testis | NA | |
| Home Discharge Rate at DRG | 47.97 | |
| Home Discharge Rate with ICD C6212 - Malignant neoplasm of descended left testis | NA |
| No | ICD Diagnosis Code | Description |
|---|---|---|
| 1 | I10 | Essential (primary) hypertension |